Deepika Grandhi, India Business Development Head of Cleveland Clinic and Founder of IMAS Healthcare, highlighted the significance of this new facility in Nagpur. She focused on three key messages:

1. The Telemedicine Center offers a unique opportunity for the people of Nagpur to access global healthcare expertise.
2. She encouraged early second opinions as a proactive approach to managing health conditions before they become critical.
3. Ms. Grandhi urged women to prioritize their health and seek second opinions to ensure they receive the best possible care.

Dr. Anup Marar, CEO (Health) MGI Director SMHRC & DBASI, and Dr. Sandeep Shrivastava, Executive Director, DMIHER Global, Datta Meghe Institute of Higher Education expressed their enthusiasm for this partnership with IMAS Healthcare in collaboration with The Clinic by Cleveland Clinic. They emphasized how this center will serve as a bridge between Nagpur and world-class medical professionals, offering patients in the region access to expert peer to peer virtual consultations.

The Telemedicine Center is set to benefit not only the people of Nagpur but also those in surrounding regions, offering preventive care, second opinions, and expert guidance from global medical leaders. By bringing advanced healthcare closer to home, this initiative is expected to raise healthcare standards and improve the quality of life for countless patients.

The post Meghe Group of Hospitals Unveils Innovative Telemedicine Center in Collaboration with IMAS Healthcare and The Clinic by Cleveland Clinic appeared first on NRI News.

The company’s mission is to reduce avoidable blindness in India by developing affordable and portable ophthalmic screening devices. This strategic investment marks a significant milestone for C3 Med-Tech, with funding the company plans to expand its presence across India and globally via marketing efforts, team building, and research and development for future products. 

Yash Nagarsheth, Founder & CEO of C3 Med-Tech, said “This investment will help us boost and accelerate our efforts to expand access, particularly in underserved communities where the need is most acute. Industrial Metal Powders is one of the largest custom surgical implant manufacturers in Southeast Asia. So we are confident that with their guidance and support, we will be able to make a meaningful impact in the fight against avoidable blindness. We are also strengthening our leadership team  with an experienced management team, along with experienced and subject matter expert ophthalmologists to guide us in developing market-relevant products.”

“We are thrilled to join hands with C3 Med-tech on their journey to revolutionize eye care from a product and,” said Prakash Dhoka, Managing Director at Industrial Metal Powders. “C3 Med-Tech’s commitment to leveraging technology for the greater good aligns perfectly with our vision of advancing medical technologies to improve lives.”

India faces a significant shortage of ophthalmologists, with only about 30,000 registered specialists serving a population of 1.3 billion. Unlike traditional eye check-up equipment that is heavy, expensive, and requires specialist operation, C3 Med-Tech addresses this critical gap with its portable, lightweight, battery-operated, and user-friendly eye screening devices.

C3 Med-Tech’s patented and US FDA-approved devices: C3 Vision-Portable Slit Lamp, C3 Smartphone Fundus Camera, and C3 Slit Lamp Imaging System offer a revolutionary approach to diagnosing eye diseases such as cataracts, diabetic retinopathy, glaucoma, corneal infections, ocular surface disorders and the majority of other eye diseases which can cause visual impairment and blindness. Their upcoming product is a very unique system for recording eye surgeries. With this product offering C3 will be covering all the facets of Ophthalmic diagnostics, right from eye screening in low-resource areas to recording eye surgeries in the Operation theatre.

C3 Med-Tech was previously incubated at one of the most prestigious Incubators in India- the Healthcare Technology Innovation Centre (HTIC) at Indian Institute of Technology Madras. They have secured multiple grants including BIG’17  from the Department of Biotechnology, Indian Government, and multiple grants from  IIT Madras Incubation Cell. Pune-based investment advisory firm INFSPL has helped C3 secure the funding.

The post C3 Med-Tech Raises INR 2 Crores In Its First Equity Investment To Launch Telemedicine & AI-enabled Eye Screening Devices appeared first on NRI News.

As the foremost medical tourism platform, MediJourney offers a comprehensive array of healthcare services, including expert consultations, medical visa support, Telemedicine, and post-treatment follow-up care. The distinguished team at MediJourney, composed of a skilled multilingual staff endorsed by medical embassies, ensures a seamless experience for patients throughout their medical journeys.

Vikaas Gutgutia, Founder & MD at Ferns N Petals, states, “MediJourney is not just a platform; it’s a heartfelt commitment to global well-being. The streamlined processes at MediJourney aim to eliminate stress, ensuring that every patient’s journey is met with compassion and care. For us, the patient always comes first, marking a new era in global medical tourism”

Rishabh Jalan, Co-founder, of MediJourney, shares, “At MediJourney, we redefine global healthcare excellence by streamlining medical travel. Our meticulous process encompasses scheduling appointments, facilitating visa arrangements, coordinating accommodations and travel, and providing personalized interpreter services. Our commitment extends beyond treatment, ensuring efficient follow-up for a comprehensive healthcare experience.”

MediJourney excels not only in service but also offers a diverse range of treatments across 30+ segments, including cardiology, oncology, eye surgery, and In Vitro Fertilization (IVF). Collaborating with 1500+ esteemed doctors and surgeons and affiliating with over 300 renowned hospitals globally, such as Fortis, Apollo, and Medanta, MediJourney provides top-notch facilities tailored to meet the unique needs of every patient.                                

Based in Delhi, MediJourney currently has a presence in Bangladesh and Dubai extending its expertise globally. The company aspires to be the treatment partner of choice for embassy officials and expatriates in India. The vision is to promote India as the preferred destination for medical treatment, offering robust support to citizens seeking healthcare services in the country.

The post Ferns N Petals Launches “MediJourney” – A Global Medical Tourism Venture appeared first on NRI News.